`
| Publications Arising from Neuropathology Consortium Studies |
| Aberg K, Saetre P, Jareborg N, Jazin E. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci USA 2006;103(19):7482-7487. |
| Agam G, Shaltiel G, Kozlovsky N, Shimon H, Belmaker RH. Corrigendum to "Lithium inhibitable enzymes in postmortem brain of bipolar patients" [J Psychiatr Res 2003;37(5):433-442]. J Psychiatr Res 2003;37(6):557. |
| Agam G, Shaltiel G, Kozlovsky N, Shimon H, Belmaker RH. Lithium inhibitable enzymes in postmortem brain of bipolar patients. J Psychiatr Res 2003;37(5):433-442. |
| Altar CA, Jurata LW, Charles V, Lemire A, Liu P, Bukhman Y, Young TA, Bullard J, Yokoe H, Webster MJ, Knable MB, Brockman JA. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry 2005;58(2):85-96. |
| Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005;10:309-322. |
| Aston C, Jiang L, Sokolov BP. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosci Res 2004;77:858-866. |
| Barley K, Dracheva S, Byne W. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res 2009;112:54-64. |
| Bayer TA, Schramm M, Feldmann N, Knable MB, Falkai P. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2000;24(6):881-888. |
| Beasley C, Cotter D, Everall I. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder. Schizophr Res 2002;58(1):63-67. |
| Beasley C, Cotter D, Khan N, Pollard C, Sheppard P, Varndell I, Lovestone S, Anderton B, Everall I. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 2001;302(2-3):117-120. |
| Beasley CL, Chana G, Honavar M, Landau S, Everall IP, Cotter D. Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders. Schizophr Res 2005;73(1):69-78. |
| Beasley CL, Cotter DR, Everall IP. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depression [abstract]. Schizophr Res 2002;53(3)(suppl):105. |
| Beasley CL, Cotter DR, Everall IP. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Mol Psychiatry 2002;7(6):564-570. |
| Beasley CL, Honavar M, Everall IP, Cotter D. Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder. Schizophr Res 2009;115(2-3): 156-162. |
| Beasley CL, Honer WG, Bergmann K, Falkai P, Lutjohann D, Bayer TA. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005;7(5):449-455. |
| Beasley CL, Pennington K, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in schizophrenia, bipolar disorder and major depressive disorder: evidence for disease-associated changes. Proteomics 2006;6(11):3414-3425. |
| Beasley CL, Zhang ZJ, Patten I, Reynolds GP. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 2002;52(7):708-715. |
| Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry 2009;14(6):601-613. |
| Ben-Shachar D, Karry R. Sp1 expression is disrupted in schizophrenia: a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS ONE 2007;2(9):e817 |
| Beneyto M, Meador-Woodruff JH. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008;33(9):2175-2186. |
| Bezchlibnyk YB, Wang JF, McQueen GM, Young LT. Gene expression differences in bipolar disorder revealed by cDNA array analysis of postmortem frontal cortex. J Neurochem 2001;79(4):826-834. |
| Bown C, Wang JF, MacQueen G, Young LT. Increased temporal cortex ER stress proteins in depressed subjects who died by suicide. Neuropsychopharmacology 2000;22(3):327-332. |
| Brauch RA, Adnan El-Masri M, Parker JC Jr, El-Mallakh RS. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals. J Affect Disord 2006;91(1):87-90. |
| Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O'Donovan MC. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 2005;14(14):1947-1954. |
| Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Moscow) 2007;72(5):578-582. |
| Burnet PW, Harrison, PJ. Substance P (NK1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia. Biol Psychiatry 2000;47(1):80-83. |
| Byne W, Tatusov A, Yiannoulos G, Vong GS, Marcus S. Effects of mental illness and aging in two thalamic nuclei. Schizophr Res 2008 Oct 2 [Epub ahead of print]. |
| Caberlotto L, Hurd YL. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. Neuroreport 1999;10(8):1747-1750. |
| Carletti R, Corsi M, Melotto S, Caberlotto L. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Eur J Neurosci 2005;21(6):1712-1718. |
| Chana G, Everall I, Cotter D. A stereological study of the mediodorsal (MD) nucleus of the thalamus in schizophrenia, bipolar disorder and major depressive disorder [abstract]. Schizophr Res 2002;53(3)(suppl):103. |
| Chana G, Landau S, Beasley C, Everall IP, Cotter D. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry 2003;53(12):1086-1098. |
| Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001;50(4):260-265. |
| Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008;100(1-3):270-280. |
| Clinton SM, Meador-Woodruff JH. Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 2004;29(7):1353-1362. |
| Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 2003;60(1):65-69. |
| Cotter D, Hudson L, Landau S. Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disord 2005;7(4):358-369. |
| Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L, Everall I. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002;51(5):377-386. |
| Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002;12(4):386-394. |
| Cotter D, Mackay D, Frangou S, Hudson L, Landau S. Cell density and cortical thickness in Heschl's gyrus in schizophrenia, major depression and bipolar disorder. Br J Psychiatry 2004;185:258-259. |
| Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001;58(6):545-553. |
| Cotter DR, Mackay D, Beasley CL, Everall IP, Landau S. The density, size and spatial pattern distribution of neurons and glia in area 9 prefrontal cortex in schizophrenia, bipolar disorder and major depression [abstract]. Schizophr Res, 2002;53(3)(suppl):107-108. |
| Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001;55(5):585-595. |
| Damadzic R, Bigelow LB, Krimer LS, Goldenson DA, Saunders RC, Kleinman JE, Herman MM. A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. Brain Res Bull 2001;55(5):611-618. |
| Damadzic R, Shuangshoti S, Giblen G, Herman MM. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Acta Neuropathol 2002;103(5):488-494. |
| De Luca V, Hlousek D, Likhodi O, Van Tol HH, Kennedy JL, Wong AH. The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses. Genes Brain Behav 2006;5(1):107-110. |
| Link for more info: eutils.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db |
| DeOliveira RMW, Deakin JFW, Guimaraes FS. Neuronal nitric oxide synthase (NNOS) expression in the hippocampal formation of patients with schizophrenia and affective disorder [abstract]. Schizophr Res 2001;49(1-2)(suppl):82-83. |
| Dowlatshahi D, MacQueen G, Wang JF, Chen B, Young LT. Increased hippocampal supragranular Timm staining in subjects with bipolar disorder. Neuroreport 2000;11(17):3775-3778. |
| Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 1999;73(3):1121-1126. |
| Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998;352(9142):1754-1755. |
| Doyle C, Deakin JFW. Fewer astrocytes in frontal cortex in schizophrenia, depression and bipolar disorder [abstract]. Schizophr Res 2002;53(3)(suppl):106. |
| Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res 2009;43(14):1175-1184. |
| Eastwood SL, Harrison PJ. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 2000;5(4):425-432. |
| Eastwood SL, Harrison PJ. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders: a review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 2001;55(5):569-578. |
| Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3B signaling in schizophrenia. Nat Genet 2004;36(2):131-137. |
| Emamian ES, Karayiorgou M, Gogos JA. Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with schizophrenia. J Neurosci 2004;24(7):1561-1564. |
| Fatemi H, Earle JA, Stary JM, Lee S, Sedgewick J. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia. NeuroReport 2001;12(15):3257-3262. |
| Fatemi SH, Earle JA, McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000;5(6):654-663. |
| Fatemi SH, Laurence JA, Araghi-Niknam M, Stary JM, Schulz SC, Lee S, Gottesman II. Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophr Res 2004;69(2-3):317-323 |
| Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E. GABAergic dysfunction in schizophrenia and mood disorders reflected by decreased levels of glutamic acid decarboxylase and 67 kDa and reelin proteins in cerebellum. Schizophr Res 2005;72:109-122. |
| Gabriele JP, Chong VZ, Pontoriero GF, Mishra RK. Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium. Schizophr Res 2005;74(1):111-119. |
| Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 2006;70:221-227. |
| Gilmore JH, Bouldin TW. Analysis of ependymal abnormalities in subjects with schizophrenia, bipolar disorder, and depression. Schizophr Res 2002;57(2-3):267-271. |
| Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A, Costa E. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005;102(26):9341-9346. |
| Guidotti A, Auta J, Davis JM, DiGiorgi Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000;57(11):1061-1069. |
| Guidotti A, Ruzicka W, Grayson DR, Veldic M, Pinna G, Davis JM, Costa E. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 2007;18(1):57-60. |
| Guilfoyle DN, Helpern JA, Lim KO. Diffusion tensor imaging in fixed brain tissue at 7.0 T. NMR Biomed 2003;16(2):77-81. |
| Herringa RJ, Roseboom PH, Kalin NH. Decreased amygdala CRF-binding protein mRNA in post-mortem tissue from male but not female bipolar and schizophrenic subjects. Neuropsychopharmacology 2006;31:1822-1831. |
| Link for more info: www.acnp.org/citations/Npp010406050477/default.pdf |
| Hobbs JA. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex. J Neurovirol 2006;12(3):190-199. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| Hurd YL. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex. Mol Psychiatry 2002;7(1):75-81. |
| Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004;9(4):406-416. |
| Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 2003;346(3):169-172. |
| Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry 2000;48(7):641-650. |
| Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry 2004;161(1):109-115. |
| Johnston NL, Cervenak J, Shore AD, Torrey EF, Yolken RH. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium. J Neurosci Methods 1997;77(1):83-92. |
| Johnston-Wilson NL, Sims CD, Hofmann J-P, Anderson L, Shore AD, Torrey EF, Yolken RH. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry 2000;5(2):142-149. |
| Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA, Altar CA. Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods 2004;138(1-2):173-188. |
| Kakiuchi C, Ishiwata M, Kametani M, Nelson C, Iwamoto K, Kato T. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int J Neuropsychopharmacol 2005;8(4):515-522. |
| Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry 2004;55(7):676-684. |
| Kim S, Webster MJ. Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 2008 Sep 2 [Epub ahead of print]. |
| Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF. Abnormalities in the cingulate gyrus in bipolar disorder and other severe psychiatric illnesses: post-mortem findings from the Stanley Foundation Neuropathology Consortium and literature review. Clin Neurosci Res 2002;2(3-4):171-181. |
| Knable MB, Barci BM, Bartko JJ, Webster MJ, Torrey EF. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CART) analysis of post-mortem prefrontal markers. Mol Psychiatry 2002;7(4):392-404. |
| Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: post-mortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004;9(6):544[image],609-620. |
| Knable MB, Barci BM, Webster MJ, Torrey EF. Summary of prefrontal molecular abnormalities in the Stanley Foundation Neuropathology Consortium. In Agam G, Belmaker RH, Everall I (eds), The Post-Mortem Brain in Psychiatric Research (Boston: Kluwer Academic Publishers, 2002). |
| Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001;55(5):651-659. |
| Knable MB, Webster MJ. Forward. Brain Res Bull 2001; 55(5):567-568. |
| Knable MB. Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection. Schizophr Res 1999;39(2):149-152. |
| Koh PO, Bergson C, Undie AS, Goldman-Rakic PS, Lidow MS. Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. Arch Gen Psychiatry 2003;60(3):311-319. |
| Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci USA 2003;100(1):313-317. |
| Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, Bernstein J, Bening-Abu-Shach U, Ben-Asher E, Lancet D, Ritsner M, Navon R. Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004;56(3):169-176. |
| Kozlovsky N, Belmaker RH, Agam G. Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res 2001;52(1-2):101-105. |
| Kozlovsky N, Belmaker RH, Agam G. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 2000;157(5):831-833. |
| Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman JE, Belmaker RH, Agam G. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm 2004;111(12):1583-1592. |
| Kristiansen LV, Meador-Woodruff JH. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression. Schizophr Res 2005;78(1):87-93. |
| Kromkamp M, Uylings HBM, Smidt MP, Hellemons AJCGM, Burbach JPH, Kahn RS. Decreased thalamic expression of the homeobox gene DLX1 in psychosis. Arch Gen Psychiatry 2003;60(9):869-874. |
| Kuromitsu J, Yokoi A, Kawai T, Nagasu T, Aizawa T, Haga S, Ikeda K. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Gene Expr Patterns 2001;1(1):17-21. |
| Kyosseva SV. Mitogen-activated protein kinase signaling. Int Rev Neurobiol 2004;59:201-220. |
| Laifenfeld D, Karry R, Grauer E, Klein E, Ben-Shachar D. ATF2, a member of the CREB/ATF family of transcription factors, in chronic stress and consequent to antidepressant treatment: animal models and human post-mortem brains. Neuropsychopharmacology 2004;29(3):589-597. |
| Laifenfeld D, Karry R, Klein E, Ben-Shachar D. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study. Biol Psychiatry 2005;57(7):716-725. |
| Law AJ and Deakin JFW. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. NeuroReport 2001;12(13):2971-2974. |
| Law AJ, Harrison PJ. Neurofilament proteins as markers of subpopulations of pyramidal neurons: the prefrontal cortex in schizophrenia [abstract]. Schizophr Res 2002;53(3)(suppl):106. |
| Law AJ, Harrison PJ. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. J Psychiatr Res 2003;37(6):487-499. |
| Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 2007;27(3):351-358. |
| López-Figueroa AL, Norton CS, López-Figueroa MO, Armellini-Dodel D, Burke S, Akil H, López JF, Watson SJ. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004;55(3):225-233. |
| Lopez-Figueroa AL, Watson SJ, Lopez-Figueroa MO. [Use of the genetic chip technology to study nitric oxide synthase]. Rev Neurol 2001;33(6):555-560. |
| Maida ME, Hurley SD, Daeschner JA, Moore AH, O'Banion MK. Cytosolic prostaglandin E(2) synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease. Brain Res 2006;1103(1):164-172. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| Manaye KF, Lei DL, Tizabi Y, Davila-Garcia MI, Mouton PR, Kelly PH. Selective neuron loss in the paraventricular nucleus of hypothalamus in patients suffering from major depression and bipolar disorder. J Neuropathol Exp Neurol 2005;64(3):224-229. |
| Marazziti D, Giannaccini G, Giromella A, Betti L, Pesce D, Nardi I, Rossi A, Lucacchini A, Battista Cassano G. [3H]-ketanserin binding sites in different psychiatric disorders. Neurochem Int 2003;42(6):511-516. |
| Marx CE, Stevens RD, Shampine LJ, Uzunova V, Trost WT, Butterfield MI, Massing MW, Hamer RM, Morrow AL, Lieberman JA. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology. 2006;31(6):1249-1263. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| McCullumsmith RE, Meador-Woodruff JH. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002;26(3):368-375. |
| McNamara RK, Hahn C-G, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007;62:17-24. |
| Meador-Woodruff JH, Hogg AJ Jr, Smith RE. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 2001;55(5):631-640. |
| Mei J, Kolbin D, Kao H-T, Porton B. Protein expression profiling of postmortem brain in schizophrenia. Schizophr Res 2006;84:204-213. |
| Miller CL, Dulay JR. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia. Brain Res Bull 2008;77(1):33-41. |
| Miller CL, Llenos IC, Cwik M, Walkup J, Weis S. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Neurochem Int 2008;52(6):1297-1303. |
| Mimmack ML, Brooking J, Bahn S. Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biol Psychiatry 2004;55(4):337-345. |
| Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RL, McKenna PJ, Jones PB, Arai H, Starkey M, Emson PC, Bahn S. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci USA 2002;99(7):4680-4685. |
| Mueller HT, Meador-Woodruff J. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression, and bipolar disorder. Schizophr Res 2004;71(2-3):361-370. |
| Munakata K, Iwamoto K, Bundo M, Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry 2005;57:525-532. |
| Nadri C, Dean B, Scarr E, Agam G. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients. Schizophr Res 2004;71(2-3):377-382. |
| Noga JT, Wang H. Further postmortem autoradiographic studies of AMPA receptor binding in schizophrenia. Synapse 2002;45(4):250-258. |
| Novak G, Kim D, Seeman P, Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Molec Brain Res 2002;107(2):183-189. |
| Nudmamud S, Reynolds LM, Reynolds GP. Decreased concentration of N-acetylaspartate in superior temporal cortex in schizophrenia and bipolar disorder [abstract]. Schizophr Res 2002;53(3)(suppl):151. |
| Nudmamud S, Reynolds LM, Reynolds GP. N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study. Biol Psychiatry 2003;53(12):1138-1141. |
| Nudmamud-Thanoi S, Reynolds GP. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 2004;372(1-2):173-177. |
| O'Connor JA, Hemby SE. Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia. Schizophr Res 2007;97:277-288. |
| O'Connor JA, Muly EC, Arnold SE, Hemby SE. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr Res 2007;90:28-40. |
| Oliveira RM, Guimaraes FS, Deakin JF. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 2008;41(4):333-341. |
| Öngür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998;95(22):13290-13295. |
| Peckys D, Hurd YL. Prodynorphin and kappa opioid receptor mRNA expression in the cingulate and prefrontal cortices of subjects diagnosed with schizophrenia or affective disorders. Brain Res Bull 2001;55(5):619-624. |
| Pennington K, Dicker P, Dunn MJ, Cotter DR. Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia. Proteomics 2008;8:5097-5107. |
| Pennington K, Dicker P, Hudson L, Cotter DR. Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders. Schizophrenia Research 2008;106:164-171. |
| Perlman WR, Tomaskovic-Crook E, Montague DM, Webster MJ, Rubinow DR, Kleinman JE, Weickert CS. Alteration in Estrogen Receptor alpha mRNA Levels in Frontal Cortex and Hippocampus of Patients with Major Mental Illness. Biol Psychiatry 2005;58(10):812-824. |
| Perlman WR, Webster MJ, Kleinman JE, Weickert CS. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 2004;56(11):844-852. |
| Polesskaya OO, Haroutunian V, Davis KL, Hernandez I, Sokolov BP. Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia. J Neurosci Res 2003;74(1):111-122. |
| Polesskaya OO, Sokolov BP. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002;67(6):812-822. |
| Regenold WT, Phatak P, Kling MA, Hauser P. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders. Mol Psychiatry 2004;9(8):731-733. |
| Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley, KC. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 2007;151(3):179-188. |
| Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, Lesch KP. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 2006;11(5):514-522. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| Reynolds GP, Beasley CL, Zhang ZJ. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J Neural Transm 2002;109(5-6):881-889. |
| Reynolds GP, Zhang ZJ, Beasley CL. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res Bull 2001;55(5):579-584. |
| Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol Psychiatry 2007;12:385-397. |
| Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006;11:965-978. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&db=pubmed& |
| Sabunciyan S, Kirches E, Krause G, Bogerts B, Mawrin C, Llenos IC, Weis S. Quantification of total mitochondrial DNA and mitochondrial common deletion in the frontal cortex of patients with schizophrenia and bipolar disorder. J Neural Transm 2007;114:665-674. |
| Schramm M, Falkai P, Feldmann N, Knable MB, Bayer TA. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci Lett 1998;257(2):65-68. |
| Selemon LD, Begovic A. Stereologic analysis of the lateral geniculate nucleus of the thalamus in normal and schizophrenic subjects. Psychiatry Res 2007;151:1-10. |
| Shaltiel G, Kozlovsky N, Belmaker RH, Agam G. 3'(2')-phosphoadenosine 5'-phosphate phosphatase is reduced in postmortem frontal cortex of bipolar patients. Bipolar Disord 2002;4(5):302-306. |
| Shamir A, Elhadad (Rosolio) N, Belmaker RH, Agam G. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder. Bipolar Disord 2005;7(1):42-48. |
| Shamir A, Shaltiel G, Levi I, Belmaker RH, Agam G. Postmortem Parietal Cortex TPH2 Expression Is Not Altered in Schizophrenic, Unipolar-Depressed, and Bipolar Patients vs Control Subjects. J Mol Neurosci 2005;26(1):33-38. |
| Shapiro J, Belmaker RH, Biegon A, Seker A, Agam G. Scyllo-inositolin post-mortem brain of bipolar, unipolar and schizophrenic patients. J Neural Transm 2000;107(5):603-607. |
| Skoblenick KJ, Castellano JM, Rogoza RM, Dyck BA, Thomas N, Gabriele JP, Chong VZ, Mishra RK. Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment. Apoptosis 2006;11(5):663-672. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| Sokolov BP, Jiang L, Trivedi NS, Aston C. Transcription profiling reveals mitochondrial, ubiquitin and signaling systems abnormalities in postmortem brains from subjects with a history of alcohol abuse or dependence. J Neurosci Res 2003;72(6):756-767. |
| Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium. Brain Res Bull 2001;55(5):625-629. |
| Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004;113(9):1353-1363. |
| Thomas AJ, Davis S, Ferrier IN, Kalaria RN, O'Brien JT. Elevation of cell adhesion molecule immunoreactivity in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry 2004;55(6):652-655. |
| Thompson M, Weickert CS, Wyatt E, Webster M. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res 2009 Mar 23 [Epub ahead of print]. |
| Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003;362(9386):798-805. |
| Tochigi M, Iwamoto K, Bundo M, Komori A, Sasaki T, Kato N, Kato T. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biol Psychiatry 2008;63:530-533. |
| Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 2008;60:184-191. |
| Toro CT, Hallak JEC, Dunham JS, Deakin JFW. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci Lett 2006;404(3):276-281. |
| Torrey EF, Barci BM, Bartko JJ, Webster MJ, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005;57:252-260. |
| Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 2000;44(2):151-155. |
| Tunbridge E, Burnet PW, Sodhi MS, Harrison PJ. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse 2004;51(2):112-118. |
| Uezato A, Meador-Woodruff JH, McCullumsmith RE. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord 2009;11(7):711-725. |
| Uranova NA, Orlovskaya DD, Vostrikov VM, Rachmanova VI. Decreased density of oligodendroglial satellites of pyramidal neurons in layer III in the prefrontal cortex in schizophrenia and mood disorders [abstract]. Schizophr Res 2002;53(3)(suppl):107. |
| Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004;67(2-3):269-275. |
| Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood WH III, Donovan DM, Webster M, Freed WJ, Becker KG. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001;55(5):641-650. |
| Vostrikov VM, Uranova NA, Orlovskaya DD. Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr Res 2007;94:273-280. |
| Wang JF, Shao L, Sun X, Young LT. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 2009;11(5):523-529. |
| Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 2001;15(4):388-400. |
| Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS, Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002;7(9):985-994. |
| Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS. Glucocorticoid receptor mRNA in human frontal cortex [image]. Mol Psychiatry 2002;7(9):924. |
| Webster MJ, O'Grady J, Kleinman JE, Weickert CS. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 2005;133(2):453-61. |
| Webster MJ, Vawter MP, Freed MJ. Immunohistochemical localization of the cell adhesion molecules Thy-1 and L1 in the human prefrontal cortex patients with schizophrenia, bipolar disorder, and depression. Mol Psychiatry 1999;4(1):46-52. |
| Webster MJ. Tissue preparation and banking. Prog Brain Res 2006;158:3-14. |
| Weickert CS, Webster MJ, Hyde TM, Herman MM, Bachus SE, Bali G, Weinberger DR, Kleinman JE. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cereb Cortex 2001;11(2):136-147. |
| Weis S, Haybaeck J, Dulay JR, Llenos IC. Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression. J Neural Transm 2008;115(5):761-771. |
| Weis S, Llenos IC, Dulay JR, Verma N, Sabunciyan S, Yolken RH. Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression. J Neural Transm 2007;114(2):261-271. |
| Weis S, Llenos IC, Sabunciyan S, Dulay JR, Isler L, Ryolken R, Perron H. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J Neural Transm 2007;114:645-655. |
| Weis S, Llenos IC. GFAP-immunopositive astrocytes in schizophrenia. Schizophr Res 2004;67(2-3):293-295. |
| Wong AH, Likhodi O, Trakalo J, Yusuf M, Sinha A, Pato CN, Pato MT, Van Tol HH, Kennedy JL. Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder. Schizophr Res 2005;78(2-3):137-146. |
| Xing G, Chavko M, Zhang L-X, Yang S, Post RM. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr Res 2002;58(1):21-30. |
| Xing G, Russell S, Hough C, O'Grady J, Zhang L, Yang S, Zhang L-X, Post R. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 2002;13(4):501-505. |
| Xing GQ, Russell S, Webster MJ, Post RM. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 2004;7(2):143-153. |
| Yolken RH. Subtraction libraries for the molecular characterization of gene-environmental interactions in bipolar disorder. Bipolar Disord 2002;4(suppl 1):77-80. |
| Young KA, Bonkale WL, Holcomb LA, Hicks PB, German DC. Major depression, 5HTTLPR genotype, suicide and antidepressant influences on thalamic volumes. Br J Psychiatry 2008;192:285-289. |
| Young KA, Holcomb LA, Bonkale WL, Hicks PB, Yazdani U, German DC. 5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system. Biol Psychiatry 2007;61(6):813-818. |
| Link for more info: www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retriev |
| Young KA, Holcomb LA, Yazdani U, Hicks PB, German DC. Elevated neuron number in the limbic thalamus in major depression. Am J Psychiatry 2004;161(7):1270-1277. |
| Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000;47(11):944-953. |
| Young LT, Bezchlibnyk YB, Chen B, Wang JF, MacQueen GM. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide and drug treatment. Biol Psychiatry 2004;55(6):570-577. |
| Zavitsanou K, Katsifis A, Mattner F, Huang X-F. Investigation of M1/M4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder. Neuropsychopharmacology 2004;29(3):619-625. |
| Zavitsanou K, Katsifis A, Yu Y, Huang XF. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders. Brain Res Bull 2005;65(5):397-403. |
| Zhang Z, Sun J, Reynolds GP. A selective reduction in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia patients. Chin Med J (Engl) 2002;115(6):819-823. |
| Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002;55(1-2):1-10. |
| Top |
| Papers Submitted or In Press from Neuropathology Consortium Studies |
| Chana G, Everall I, Landau S, Cotter D. Glial cell number and nuclear size in the mediodorsal thalamic nucleus (MDNT) in schizophrenia [letter]. Schizophr Res 2008, in press. |
| DeOliveira RMW, Deakin JFW, Guimaraes FS. Increased density of hippocampal nNOS-producing neurons in unipolar and bipolar depression. Submitted. |
| Ftouh S, Hirsch SR, de Belleroche J. Significant reduction of NR1, NR2B and neuregulin in temporal cortex implicates glutamate hypofunction in schizophrenia. Submitted. |
| Gottfried Y, Rotem A, Klein E, Larisch S. The pro-apoptotic ARTS/Sept4 protein is significantly reduced in post-mortem brains from schizophrenic patients. Schizophr Res 2007;96:257-266. |
| Lowther S, Coull MA, Peacock J, Katona CL, Horton RW. Brain phosphatidylinositol turnover in affective disorders and schizophrenia. Submitted. |
| Song L, Greendorfer AJ, Bartolucci AA, Jope RS. Phosphoinositide signal transduction system and G-protein levels in postmortem brain from subjects with bipolar disorder, major depression, and schizophrenia. J Psychiatr Res. In press. |
| Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Webster MJ, Yolken RH, Bahn S. Profound metabolic abnormalities in schizophrenia. Submitted. |
| Toro CT, Ocansey P, Doyle C, Hallak JEC, Deakin JFW. The astroglial contribution to glutamate neurotransmission in schizophrenia and mood disorder: a post-mortem brain study of glutamine synthetase immunocytochemistry. Submitted. |
| Waters S, Bergh I, Carlsson A. A postmortem multivariate analysis of monoaminergic indices and S-cysteinyl-adducts in two cortical regions of patients with schizophrenia, bipolar disorder or depression, compared with controls. Submitted. |
| Weis S, Llenos IC, Dulay JR, Sabunciyan S, Torrey EF, Yolken RH. Different patterns of neutral amino acid transporter 1 (ASCT1) expression and their respective alterations in the cingulate cortex in schizophrenia, bipolar disorder and major depression. Submitted. |
| Xing Q, Post R. Reduced Nurr (NOT1) and NGFI-B (TR3) expression in the prefrontal cortex in schizophrenia and depression. Submitted. |
| Top |